Birch Triterpenes
Small Molecule
Overview
Birch Triterpenes is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4650246).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Birch Triterpenes expires 4 Jan 2039 and exclusivity 18 Dec 2030. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.